基于IL-6为表达的急性脑梗死痰热腑实证不同状态点的炎症水平变化特点的临床研究
[Abstract]:Background: as the incidence of ischemic cerebrovascular disease is increasing and the trend of the disease is becoming younger, the economic burden and mental burden of family and society have become a problem that can not be ignored. The incidence of stroke related infection (stroke-associated infection, SAI) is more severe on the condition of stroke patients. It seriously affects the prognosis of the patients and even causes the death of the patients. Therefore, early active prevention of the occurrence of SAI and timely treatment are particularly important in the clinic. Objective: using interleukin-6 (IL-6) as an indicator of inflammation, the comparison of the subgroup of the patients with acute cerebral infarction phlegm heat syndrome and SAI is to explore the SAI patients and non SAI patients. The dynamic change characteristics of IL-6 under different state points; explore the dynamic change characteristics of different state points of IL-6 under different treatment means of Fu Fu and Tong Fu in the patients with SAI, and explore the relationship between the brain, the intestines and the lung and the urinary system from the level of inflammatory reaction. Methods: 62 cases of the patients were included, according to the random control. The table method was randomly divided into the test group and the control group by the proportion of 2:1, of which 41 cases in the experimental group and 21 cases in the control group. In the test process, 1 cases were lost in the experimental group and 1 cases were eliminated in the control group. All the patients were treated with routine medical treatment plan. On this basis, the experimental group took the star Chengqi Decoction, the control group was taken orally or Enemia Glycerini / Enema Glycerini in the control group. Anus or enema. During the passage of the Fu Fu, the patients with SAI must conform to the diagnosis standard of the stroke related infection. The course of treatment is 5 + 2 days. The patient is visited daily and the information of four diagnosis is collected. All patients are tested for stroke related scale and IL-6 examination, and the patients with SAI are at the infection point. The evaluation of self-made stroke related infection scale and IL-6 test, and the evaluation of self-made stroke related infection scale again after the treatment. The safety indexes were detected before and after treatment. Results: the symptoms and signs of TCM in the 1. treatment group and the control group were divided into the symptoms and signs of TCM, and the internal wind of the score of the ischemic stroke syndrome factor scores. Internal fire, phlegm dampness, blood stasis and yin deficiency syndrome factors, total score of phlegm syndrome, NIHSS score improved (P0.05) before treatment (P0.05), but there was no difference between the two groups on Qi deficiency syndrome factors before treatment (P0.05); after 2. treatment, the treatment group and the control combination and SAI patients were self-designed for the stroke related infection scale The scores were significantly improved (P0.05), there was no difference between the groups (P0.05); the incidence of SAI in the treatment group and the control group was not different (P0.05); before 3., the IL-6 concentration level of the combined SAI patients (n=14) and the non SAI patients (n=46) was compared, the SAI group was higher than the non SAI group (P0.05), which was in accordance with the clinical practice. After treatment, to two respectively, to the clinical practice. There was no statistical difference in group comparison (P0.05), but there was no statistical difference between groups (P0.05). But after treatment, the change trend of two groups of IL-6 was different, IL-6 concentration level in group SAI decreased gradually, the concentration level of IL-6 in non SAI group increased slowly, and there was a trend near a certain value; before treatment, the combination of treatment and SAI patients (n=7) and control group There was no significant difference in the level of IL-6 concentration in the patients with SAI (n=7). There was no statistically significant difference between the two groups after treatment (P0.05), and there was no statistical difference between the groups (P0.05). The level of IL-6 concentration in the two groups was all decreased, but the decrease of IL-6 level in the treatment group was greater than that in the control group. The mean level of IL-6 concentration in the treatment group was higher than the control group before treatment, but the treatment group was lower than the control group. Before 5. treatment, there was no difference between the group of SAI patients (n=33) and the control group without SAI (n=13) in the IL-6 concentration level group (P0.05), and the difference was not statistically significant (P0.05) in the two groups after the treatment. There was no statistical difference between the two groups (P0.05). The level of IL-6 concentration in the treatment group and the control group was higher than that of the control group, but the level of IL-6 in the treatment group was higher than that of the control group. Conclusion: the change trend of the level of IL-6 in the treatment group is greater than that of the control group. Conclusion: the trend of the IL-6 level of SAI patients and non SAI patients before and after 1. treatment is different, considering the phlegm and Fu Fu organs. The action of the method is different in improving the inflammatory response of the infected people and non infected people, and there is a two-way regulating effect, but it always makes it tend to the normal range. The level of IL-6 in the patients with SAI is gradually reduced, and the decrease of the level of the IL-6 in the treatment group of Tongfu is greater than that of the.SAI patients before the treatment of.SAI. The change of the concentration level of the post IL-6 was not synchronized with the change of the WBC count, indicating that IL-6 was more sensitive to the response of the inflammatory changes with the intervention of the.3. and the defecation. The level of IL-6 in the patients without SAI was gradually increased, and the increase in the treatment group was greater. The change trend of the phlegm and Tongfu method may lead to the peak of the change of the IL-6 and restore normal. The time length shortened, but further experiments still need further experiments to prove that the concentration level of.4. accompanied with IL-6 tends to be stable, the symptoms and signs of the stroke, the symptoms of nerve function, and the positive symptoms of phlegm and heat are obviously improved, and the syndromes of internal wind, internal fire, phlegm dampness and blood stasis are obviously improved. The method of.5. phlegm and phlegm and Tong Fu can help to adjust the force of mediator of the central coke gas machine, help to adjust the balance of water metabolism, improve the accumulation of abnormal water and improve the symptoms and signs of urinary system infection, and improve the symptoms and signs of stroke related pneumonia through the "lung and the large intestine form" viscera, with the demonstration of the Fu Fu and the heat syndrome.
【学位授予单位】:北京中医药大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R277.7
【参考文献】
相关期刊论文 前10条
1 林萍;童巧文;夏作利;张有超;郑丽芬;林一均;;脑卒中患者发生卒中相关性感染的危险因素研究[J];现代预防医学;2016年13期
2 阙玉梅;莫晔;何锴;丁莉;朱滢;;脑卒中患者肺部感染体液及细胞免疫功能变化研究[J];中华医院感染学杂志;2016年11期
3 单凯;郭伟;;卒中相关性肺炎诊疗进展[J];中国卒中杂志;2016年04期
4 巫丽娟;赵丹;刘敏雪;陈知行;肖玉玲;李冬冬;康梅;谢轶;;四川大学华西医院脑卒中伴感染患者临床数据分析[J];中风与神经疾病杂志;2016年03期
5 李书恒;;脑梗死后炎性因子的动态变化研究[J];中国现代药物应用;2016年04期
6 唐林云;闫福岭;;他汀类药物与卒中后感染的研究进展[J];中华脑科疾病与康复杂志(电子版);2015年05期
7 刘惠杰;徐寅平;顾兆一;肖丁;;化痰通腑法治疗中风病急性期痰热腑实证105例临床观察[J];中国中医基础医学杂志;2015年05期
8 陈海生;;星蒌承气汤治疗重症急性期中风病的临床研究[J];辽宁中医杂志;2015年05期
9 高玉红;;饮酒与老年脑卒中患者伴发肺炎的Meta分析[J];东南国防医药;2015年02期
10 郑声浩;吴晓谦;林群力;;免疫调节剂防治脑卒中相关性感染的临床研究[J];中华医院感染学杂志;2015年06期
相关会议论文 前1条
1 李亚鹏;宋波;方慧;高远;赵璐;许予明;;A2DS2评分对中国急性缺血性卒中患者住院期间肺炎发生风险的预测作用研究[A];中华医学会第十七次全国神经病学学术会议论文汇编(下)[C];2014年
相关重要报纸文章 前1条
1 王丹;;近半中风患者是中年人[N];健康报;2015年
相关硕士学位论文 前4条
1 凌丽丽;星蒌承气汤对缺血性中风急性期患者证候变化及IL-6的影响[D];北京中医药大学;2015年
2 刘彩丽;卒中相关性肺炎的危险因素及A2DS2评分对其评价研究[D];大连医科大学;2015年
3 杨俊芳;急性缺血性脑卒中相关性肺炎的危险因素及A~2DS~2评分的预测价值研究[D];新疆医科大学;2014年
4 杨亚红;急性脑卒中相关性肺炎危险因素分析及病原学特点[D];郑州大学;2013年
,本文编号:2141379
本文链接:https://www.wllwen.com/shoufeilunwen/mpalunwen/2141379.html